The review explores the recent findings surrounding the evaluation and the treatment of patients with heart failure and coronary artery disease. It also shed the light on the gaps in this area.
Surgical revascularization in patients with ischemic cardiomyopathy has the potential to offer symptomatic and survival benefits.
Patients with heart failure and coronary artery disease should be considered candidates for revascularization on the basis of their symptoms, extent of the disease, and comorbidities. Surgical revascularization in these patients provides a symptomatic relief, and a survival benefit.
aFaculty of Medicine, University of Ottawa, Ottawa
bDepartment of Cardiac Surgery, London Health Sciences Centre, London, Ontario
cDepartment of Medicine, University of Saskatchewan, Saskatoon Health Region, Saskatoon, Saskatchewan, Canada
Correspondence to Bob Kiaii, MD, FRCSC, Department of Cardiac Surgery, London Health Sciences Centre, 339 Windermere Road, London, Ontario, N6A 5A5, Canada. Tel: +1 519 685 8500 ext. 33153; e-mail: Bob.Kiaii@lhsc.on.ca